Nonsteroidal Anti-inflammatory Drug class drugs

14 results

  • Bromsite

    (bromfenac)
    Sun Pharmaceutical Industries, Inc.
    Usage: BromSite (bromfenac ophthalmic solution) 0.075% is indicated for treating postoperative inflammation and preventing ocular pain in patients who have undergone cataract surgery.

  • Cambia

    (diclofenac potassium)
    Assertio Therapeutics, Inc.
    Usage: CAMBIA is indicated for the acute treatment of migraine attacks with or without aura in adults aged 18 and older. It is not intended for prophylactic therapy of migraine or for the treatment of cluster headache.

  • Celebrex

    (Celecoxib)
    PFIZER LABORATORIES DIV PFIZER INC
    Usage: CELEBREX is indicated for managing signs and symptoms of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (in patients aged 2 and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.

  • Duexis

    (Ibuprofen and Famotidine)
    Horizon Therapeutics USA, Inc.
    Usage: DUEXIS is indicated for relieving symptoms of rheumatoid arthritis and osteoarthritis, and for reducing the risk of upper gastrointestinal ulcers in patients taking ibuprofen for these conditions. It is primarily studied in patients under 65 without a history of gastrointestinal ulcers. Controlled trials lasted up to 6 months.

  • Naprelan

    (Naproxen Sodium)
    ALMATICA PHARMA INC.
    Usage: NAPRELAN Tablets are indicated for treating rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.

  • Omidria

    (phenylephrine and ketorolac)
    Rayner Surgical Inc.
    Usage: Omidria® is indicated for use during cataract surgery or intraocular lens replacement to maintain pupil size, prevent intraoperative miosis, and reduce postoperative ocular pain when added to an ocular irrigating solution.

  • Pennsaid

    (diclofenac sodium)
    Horizon Therapeutics USA, Inc.
    Usage: PENNSAID is indicated for the treatment of pain associated with osteoarthritis of the knee(s).

  • Prolensa

    (Bromfenac Sodium)
    Bausch & Lomb Incorporated
    Usage: PROLENSA® (bromfenac ophthalmic solution) 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.

  • Seglentis

    (celecoxib and tramadol hydrochloride)
    Kowa Pharmaceuticals America, Inc.
    Usage: SEGLENTIS is indicated for the management of acute severe pain in adults requiring opioid analgesics when alternative treatments are ineffective or intolerable. Due to addiction and misuse risks, it should only be used when other options fail to provide adequate relief.

  • Sprix

    (ketorolac tromethamine)
    Zyla Life Sciences US LLC
    Usage: SPRIX is indicated for the short-term management (up to 5 days) of moderate to moderately severe pain in adults requiring opioid-level analgesia. It is not intended for use in pediatric patients under 2 years of age.